General Updates

BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED CIN: L24233MP1985PLC002709 Registered Office: B/12-B, Industrial Estate, Pologround, Indore-452015 (M.P.) Tel. 0731-2426700; Email id- bcplcompliance@gmail.com; Website- www.biofilgroup.net; Fax: 0731-2426700 Date: 26th August, 2026 To, To, The Secretary (DCS/Compliance), The Secretary (Listing/Compliance), Corporate Relationship Department, Corporate Relationship Department, BSE Limited National Stock Exchange of India Phiroze Jeejeebhoy Towers, Limited, Dalal Street, Mumbai-400001 Exchange Plaza, C-1, Block G, Bandra Kurla Complex, Mumbai – 400051 Subject: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015- letter to those shareholders whose email addresses are not registered with Company/Registrar & Transfer Agent/Depository Participants. Reference: BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED (BSE Script Code: 524396; NSE Symbol: BIOFILCHEM; ISIN: INE829A01014) Dear Sir/Madam, With reference to the above captioned subject and in accordance with Regulation 36(1)(b) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, the Company is in process to send a letter to those shareholders whose e-mail addresses are not registered with Company/Registrar & Transfer Agent/Depository Participants, providing the web-link of the website including the exact path where complete details pertaining to the Annual Report is hosted. A copy of the above said draft letter is enclosed for your records. You are requested to kindly take the same on record for your further needful. Thanking you, Yours Faithfully, FOR, BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED APOORV JAIN COMPANY SECRETARY & COMPLIANCE OFFICER M. NO.:A71739 Encl: a/a BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED CIN: L24233MP1985PLC002709 Registered Office: B/12-B, Industrial Estate, Pologround, Indore-452015 (M.P.) Tel. 0731-2426700; Email id- bcplcompliance@gmail.com; Website- www.biofilgroup.net; Fax: 0731-2426700 Date: ….. August……., 2026 Dear Shareholder, Subject: Communication in respect of 41st Annual Report and Notice of 41st AGM pursuant to Regulation 36(1)(b) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 We are pleased to inform you that 41st Annual General Meeting (‘AGM’) of Biofil Chemicals And Pharmaceuticals Limited is scheduled to be held on Wednesday 23rd day of September, 2026 at 3:00 P.M. through Video Conferencing (VC)/Other Audio Visual Means (OAVM for the Financial Year ended 31st March, 2026 in compliance with the provisions of the Companies Act, 2013 and latest General Circular No. 03/2025 dated 22nd September, 2025 issued by the Ministry of Corporate Affairs (MCA) and SEBI Master circular no Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January, 30, 2026 read with relevant provisions of the Companies Act, 2013 and SEBI Listing Regulations. In compliance with Regulation 36(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), we wish to inform you that copy of Notice convening the 41st AGM and the Annual Report of the Company for the Financial Year (FY) 2025-26 is being sent through electronic mode to those members whose e-mail addresses are registered with the Registrar & Share Transfer Agent/ Depository Participants. We find that your email address is not registered against your Demat Account/ Folio Number. On account of this we are unable to send the annual report containing notice of AGM electronically to you. Hence pursuant to the provisions of Regulation 36(1)(b) of SEBI Listing Regulation, this letter is sent by the Company to inform you that the Annual Report for the financial year ended 31st March, 2026 along with the Notice of the 41st Annual General Meeting (AGM) is available on the web path https://biofilgroup.net/investor/regulatory disclosure/financial-reports and which can be accessed on web link https://www.biofilgroup.net/investor/financial-reports In case you wish to receive a physical copy of the Annual Report may write to us at bcplcompliance@gmail.com mentioning your Folio No./ DP Id/ Client Id. Please note that the aforesaid documents are also available on the website of Stock Exchanges that is BSE Limited www.bseindia.com and National Stock Exchange of India Limited (NSE), www.nseindia.com and on the website of CDSL at: https://www.evotingindia.com. If you wish to update or change your email address, communication address, bank details, Nomination details please approach your depository or in case you hold shares in physical form please write us at- Registrar and Share Transfer Agent – Tel.: 0731 - 4065799, 4065797 Ankit Consultancy Private Limited Email Id: investor@ankitonline.com Add:- 60, Electronic Complex, Pardeshipura, Indore (M.P.)- Website:-www.ankitonline.com 452010. We thank you for your continued support. Yours faithfully, FOR, BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED SD/- APOORV JAIN COMPANY SECRETARY & COMPLIANCE OFFICER A71739 Email: bcplcompliance@gmail.com